CRISPR-Cas9 Genome Editing

Core Concept

CRISPR-Cas9 is an RNA-guided genome-editing system adapted from a bacterial adaptive immune mechanism. A guide RNA (gRNA) base-pairs with a complementary DNA sequence, directing the Cas9 endonuclease to cut both DNA strands at that site, but only where a short PAM (protospacer-adjacent motif, e.g., 5′-NGG for S. pyogenes Cas9) is present. The resulting double-strand break (DSB) is repaired by the cell: error-prone NHEJ introduces small insertions/deletions (indels) that usually frameshift and knock out the gene, while HDR (homology-directed repair) uses a provided donor template to knock in a precise sequence. Because CRISPR edits the DNA, it produces permanent, heritable gene inactivation or modification — in contrast to RNAi, which only transiently degrades mRNA.

Key Components

Cas9 endonuclease

• A large nuclease (from Streptococcus pyogenes) with two nuclease domains (HNH and RuvC) that each cut one DNA strand, producing a blunt double-strand break ~3 bp upstream of the PAM.

Guide RNA (gRNA / sgRNA)

• A single chimeric RNA combining a crRNA (the ~20-nt sequence complementary to the target) and a tracrRNA (scaffold that binds Cas9). It determines where Cas9 cuts.

PAM (protospacer-adjacent motif)

• A short sequence (5′-NGG for SpCas9) required immediately downstream of the target; Cas9 binds and cuts only in its presence. PAM is how the system distinguishes target from the bacterium's own CRISPR array.

Donor template (for HDR)

• A DNA molecule carrying the desired edit flanked by homology arms, used to direct precise repair (knock-in, correction, tagging).

Mechanism

1. Targeting. The gRNA-Cas9 complex scans DNA for a PAM, then the gRNA's 20-nt spacer base-pairs with the adjacent target.
2. Cleavage. On a full match, Cas9's two nuclease domains cut each strand, creating a DSB.
3. Repair — NHEJ. Without a donor, the cell ligates the break by non-homologous end joining, often leaving indels that disrupt the reading frame → knockout.
4. Repair — HDR. With a donor template present (especially in S/G2 phase), homology-directed repair copies the template into the break → precise knock-in or correction.
5. Genotype. Edited cells are cloned and genotyped (sequencing) to confirm the intended mutation; off-target sites are checked.

Energy and Directionality

Cas9 catalysis itself uses no external ATP — DNA cleavage is a hydrolysis reaction — but the search/targeting process is coupled to the cell's energy economy, and the repair pathways consume ATP: NHEJ (DNA-PK, ligase IV) and HDR (Rad51 strand invasion, DNA synthesis from dNTPs) both require ATP and dNTP hydrolysis. Directionality is enforced by two sequence checkpoints: the PAM (spatial anchor) and gRNA-target complementarity (sequence specificity), so cuts occur only at the programmed locus (and at imperfectly matched off-targets).

Experimental Evidence

• What it measures/produces: targeted, permanent modification of a genomic locus — gene knockout or knock-in.
• Principle: RNA-guided Cas9 DSB followed by endogenous NHEJ or HDR repair.
• Input: Cas9 + gRNA (+ optional donor template), delivered as plasmid/RNP/virus; target cells. Output: cells/organisms with indels (knockout) or precise edits (knock-in).
• What it can prove: a gene's necessity and sufficiency (via clean knockout and rescue), the effect of a specific mutation or tagged protein, and (with HDR) causality of a variant — a rigor RNAi cannot match.
• What it cannot prove: it does not read out gene function directly (phenotypes must be assayed); mosaicism (mixed edited/unedited cells) can confuse results; and off-target edits at similar sequences can confound interpretation.
• Controls: a non-targeting gRNA (negative control); untransfected cells; Sanger/NGS sequencing of the target locus to confirm the edit; off-target analysis (predictive + sequencing of top candidate sites); rescue (re-express the gene) to confirm phenotype specificity; clonal isolation to avoid mosaicism.
• Common mistakes: using one gRNA with poor on-target efficiency; ignoring PAM requirements; confusing NHEJ and HDR outcomes; not verifying the genotype; and attributing a phenotype to on-target editing when off-target damage may be responsible.

Common confusions

• "CRISPR and RNAi both knock out genes" — CRISPR edits DNA (permanent knockout/knock-in); RNAi degrades mRNA (transient knockdown). The DNA is untouched by RNAi.
• "Cas9 cuts anywhere the gRNA matches" — Cutting also requires a PAM immediately adjacent; no PAM, no cut.
• "NHEJ and HDR are interchangeable" — NHEJ is error-prone and template-free (knockout); HDR needs a donor and homology arms (knock-in/correction).
• "CRISPR only knocks out" — With HDR it can knock in, correct, or tag genes; base editors and CRISPRi/a expand this further.
• "An edit is guaranteed clean" — Off-target edits and mosaicism are real; genotyping and off-target checks are mandatory.

Quick review

• gRNA + Cas9 → bind PAM → DSB → NHEJ (indels → knockout) or HDR (+donor → knock-in).
• Permanent DNA edit, unlike RNAi knockdown.
• Verify by sequencing; screen for off-targets; use non-targeting gRNA controls.